Historical record - last NADAC effective date: 8/22/2018
Product Information
GLYBURIDE-METFORMIN 2.5-500 MG is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0533 per EA under NDC 68382065405. Its NADAC has been published 103 times since Sep 21, 2016.
FDA first approved this application on Feb 29, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5; 500 mg/1; mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382065405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/22/2018
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206748FDA Approved
2/29/2016
TE Code
AB
On Market Since
4/7/2016
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE-METFORMIN 2.5-500 MG has been published 103 times since Sep 21, 2016, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0533 per EA |
|---|---|
| All-time high | $0.0806 (Nov 16, 2016) |
| All-time low | $0.0496 (Apr 18, 2018) |
| Median price | $0.0625 |
| Average price | $0.0624 |
| Largest weekly change | +26.8% (May 23, 2018) |
| Weeks tracked | 103 |
| Tracking since | Sep 21, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-25.2%
Last surveyed Sep 5, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE-METFORMIN 2.5-500 MG?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE-METFORMIN 2.5-500 MG, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0533 per EA (NDC 68382065405), effective Sep 5, 2018.
How has the price of GLYBURIDE-METFORMIN 2.5-500 MG changed over time?
Over the history we have for it, the NADAC for GLYBURIDE-METFORMIN 2.5-500 MG has declined 25.2%. It has been tracked across 103 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for GLYBURIDE-METFORMIN 2.5-500 MG?
Since Sep 21, 2016, the NADAC for GLYBURIDE-METFORMIN 2.5-500 MG has ranged from a low of $0.0496 (Apr 18, 2018) to a high of $0.0806 (Nov 16, 2016), with a median of $0.0625 per EA.
Are there cheaper alternatives to GLYBURIDE-METFORMIN 2.5-500 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GLYBURIDE-METFORMIN 2.5-500 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GLYBURIDE-METFORMIN 2.5-500 MG?
GLYBURIDE-METFORMIN 2.5-500 MG (NDC 68382065405) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.